TScan Therapeutics

TScan Therapeutics

  • Founded: 2018
  • Location: Waltham, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: AML, MDS, ALL
  • Drug types: ONC
  • Lead product: TSC-100
  • Product link: https://www.tscan.com/pipeline/
  • Funding: $140M stock May 2023; $100M IPO Jul 2021; $100M C Jan 2021



job board

Short description:

T Cell Therapies

Drug notes:

TSC-101 Clin1 AML, MDS, ALL; TSC-204 5 efforts RD/Clin1 solid tumors; TSC-200 3 efforts RD/Clin0 solid tumors; TSC-203 2 efforts RD/Clin0 solid tumors; TSC-201 3 efforts RD solid tumors; TSC-202 RD solid tumors; TSC-205 RD solid tumors

Long description:

Contact us to add description: recruit@workinbiotech.com


TScan Therapeutics
MA08-5 Manufacturing Associate/Sr. Manufacturing A...
Waltham, MA, US|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com